Sekisui Chemical Co., Ltd. · TSE:4204

Sekisui Chemical — FY2023 Earnings Presentation

50 slides from Sekisui Chemical's earnings presentation, Apr 26, 2024

  1. Slide 1: Presentation of Financial Results and the FY2024 Management Plan

    SEKISUI CHEMICAL CO., LTD. For FY2023, ended March 31, 2024 Presentation of Financial Results and the FY2024 Management Plan Keita Kato President and CEO April 26, 2024

  2. Slide 2: Main Points of Today's Presentation

    Main Points of Today’s Presentation ★:Record high Compared Difference from Compared FY2023 FY2024 with Forecasts with Results Plan (JPY billion) FY2022 (January 2024) FY2023 Net sales ★ 1,256.5 +14.0 -5.8 ★ 1,326.7 +70.2 Operating profit 94.4 +2.7 -0.6 ★ 102.0 +7.6 Ordinary profit ★ 105.9 +1.7 +2.9

  3. Slide 3: Drive 2.0 Progress

    Drive 2.0 Progress 1. Investment Plan and Progress  While progress in FY2023 was sluggish due to a slump in market conditions, increase in growth investment projects from FY2024 (JPY billion)  Continue to search for M&A and other opportunities, focusing on growth areas Operating cash flows Debt +

  4. Slide 4: Returns to Shareholders

    Returns to Shareholders ▌ Continue to actively provide returns to shareholders in FY2024; plans for a fifteenth consecutive FY of dividend growth Previous Medium-term Medium-term Returns to Shareholders Track Record (JPY billion) Management Plan Management Plan Acquisition of treasury shares Dividen

  5. Slide 5: FY2023 Results

    FY2023 Results FY2022 FY2023 Forex rate 1H 2H 1H 2H In-house ¥146/US$ ‐ ‐ - assumptions ¥159/€ Futoshi Kamiwaki Results ¥134/US$ ¥137/US$ ¥141/US$ ¥148/US$ (Avg. rate for ¥139/€ ¥143/€ ¥153/€ ¥160/€ each term) Representative Director * Export data is subject to in-house assumptions regarding foreign

  6. Slide 6: Overview of FY2023 Results

    Overview of FY2023 Results ▌ Increase in net sales; second consecutive FY of record-high sales ▌ Increase in profit (operating profit, ordinary profit, and the bottom line) ▌ Record highs in ordinary profit and the bottom line owing mainly to foreign exchange gains and such factors as the gain on sa

  7. Slide 7: FY2023 Results by Segment

    FY2023 Results by Segment ▌ Substantial increase in HPP Company operating profit; record highs in HPP and UIEP operating profit; decreases in Housing Company and Medical Business operating profit • HPP*: Substantial increase in net sales and operating profit mainly in the Mobility field owing to the

  8. Slide 8: 1H & 2H FY2023 Results by Segment

    1H & 2H FY2023 Results by Segment ▌ Substantial increase in 2H HPP operating profit driven by the Mobility field; continued steady increase in UIEP operating profit; despite a downturn in Housing operating profit, impacted significantly by a drop in orders in the 1H, progress in promoting measures t

  9. Slide 9: FY2023 Results Analysis

    FY2023 Results Analysis ▌ Despite continued sluggish market conditions (delays in a recovery in housing market conditions in Japan and in semiconductor-related activities), secured increases in net sales and operating profit through thoroughgoing efforts to secure margins ▌ Despite a decline in sale

  10. Slide 10: FY2024 Plan

    FY2024 Plan FY2023 FY2024 Forex rate 1H 2H 1H 2H In-house ¥150/US$ ¥150/US$ assumptions ‐ ‐ ¥161/€ ¥161/€ Results ¥141/US$ ¥148/US$ (Avg. rate for - - each term) ¥153/€ ¥160/€ * Export data is subject to in-house assumptions regarding foreign currency exchange rates. A ¥1 depreciation in the value o

  11. Slide 11: FY2024 Plan: Overview and Returns to Shareholders

    FY2024 Plan: Overview and Returns to Shareholders ▌ Planning increases in net sales and profit (operating profit, ordinary profit, and bottom line) ▌ Target record-high net sales, operating profit and bottom line ▌ Plan to pay a dividend per share of ¥75, up ¥1 (fifteenth consecutive FY of dividend

  12. Slide 12: Outlook for Market Conditions

    Outlook for Market Conditions Number of Automobiles Manufactured (YoY) Housing・Visitors (YoY) 4Q FY2023: Results slightly below expectations 2H FY2023: Recovery in the number of overall visitors essentially in FY2024: Forecasts at the same level as the previous year line with the previous year FY202

  13. Slide 13: FY2024 Plan by Segment

    FY2024 Plan by Segment ▌ Increases in net sales and operating profit in each segment; plans for record- high segment operating profit excluding the Housing Company • HPP: Forecasting growth in the Mobility field and a recovery in Electronics-related demand focusing on semiconductors; plans for a sub

  14. Slide 14: 1H & 2H FY2024 Plans by Segment

    1H & 2H FY2024 Plans by Segment ▌ Forecasting a modest recovery in market conditions; secure an increase in net sales and operating profit with the HPP Company continuing to drive the Group as a whole in the 1H; plans for an increase in net sales and operating profit across all segments in the 2H ▌

  15. Slide 15: FY2024 Plan Analysis

    FY2024 Plan Analysis ▌ Expecting a gradual recovery in global market conditions as well as housing market conditions in Japan; forecasting a substantial increase in sales volumes and product mix on the back of high-performance product sales growth and efforts to cultivate new customers ▌ Despite exp

  16. Slide 16: Consolidated Performance

    Consolidated Performance ▌ Continue to work toward business portfolio reform and accelerate the shift to further growth; target operating profit of ¥102 billion (JPY billion) EBITDA 119.9 119.3 126.7 133.4 137.7 137.3 133.2 116.6 137.6 142.1 147.1 159.0 1,326.7 1,242.5 1,256.5 1,157.9 1,142.7 1,129.

  17. Slide 17: Financial Results FY2023

    Financial Results FY2023 Tatsuya Nishida Managing Executive Officer Head of Corporate Finance & Accounting Department 16

  18. Slide 18: Consolidated Companies

    Consolidated Companies Number of Consolidated Companies Mar. 31, 2023 Mar. 31, 2024 Difference Consolidated Increased: 0 Subsidiaries subsidiaries 148 143 Decreased: 5 Subsidiaries*1 Affiliates Increased: 0 Subsidiaries 7 6 (Equity Method) Decreased: 1 Subsidiary*2 *1 Sekisui (Shanghai) Environmenta

  19. Slide 19: Summary of Profit and Loss

    Summary of Profit and Loss + FY2022 FY2023 Difference (JPY billion) Foreign exchange gains: +5.2 Net sales 1,242.5 1,256.5 +14.0 Gross profit 377.2 392.2 +15.0 Foreign exchange gains: +7.0 Gross profit margin 30.4% 31.2% +0.9% Selling, general and administrative expenses 285.6 297.8 +12.2 Exclusion

  20. Slide 20: Balance Sheets (Assets)

    Balance Sheets (Assets) Mar.31 Inventories (B/S item) 2024 Difference Ready-built housing (products) 38.0 +5.3 Prepared land for subdivision Mar. 31, 2023 Mar. 31, 2024 Difference housing 67.7 +3.5 (JPY billion) Land under preparation (work in process) 10.5 +0.5 Cash and deposits 101.1 138.6 +37.5 H

  21. Slide 21: Balance Sheets (Liabilities & Net Assets)

    Balance Sheets (Liabilities & Net Assets) (JPY billion) Mar. 31, 2023 Mar. 31, 2024 Difference Non-interest-bearing liabilities 375.1 381.6 +6.4 Net profit: +77.9 Interest-bearing liabilities 120.5 120.7 +0.3 Dividends paid: -27.8 [Net interest-bearing liabilities] [19.4] [-17.8] [-37.2] Total liabi

  22. Slide 22: Consolidated Cash Flows

    Consolidated Cash Flows (JPY billion) FY2022 FY2023 Cash flows from operating activities 71.5 106.6 Cash flows from investing activities -59.4 -18.5 Cash flows from financing activities -62.9 -53.0 Net increase in cash and cash equivalents -48.5 41.2 Cash and cash equivalents at end of period 85.2 1

  23. Slide 23: Depreciation, Amortization, Capital Expenditures and EBITDA

    Depreciation, Amortization, Capital Expenditures and EBITDA ★:Record high Goodwill and other Depreciation*1 Capital expenditures EBITDA*3 amortization*2 Differ- Differ- Differ- Differ- FY2022 FY2023 FY2022 FY2023 FY2022 FY2023 FY2022 FY2023 ence ence ence ence (JPY billion) Housing 11.1 11.6 +0.5 0.

  24. Slide 24: Depreciation, Amortization, Capital Expenditures, Research and Development Expenditure

    Depreciation, Amortization, Capital Expenditures, Research and Development Expenditure ★:Record high FY2024 FY2023 Difference (JPY billion) Plan Depreciation 50.0 54.3 +4.3 Goodwill and other amortization 2.7 2.7 0 Capital expenditures 60.6 75.0 +14.4 EBITDA 147.1 ★ 159.0 +11.9 Research and developm

  25. Slide 25: High Performance Plastics Company

    High Performance Plastics Company Ikusuke Shimizu Company President 24

  26. Slide 26: HPP Company Performance Trends

    HPP Performance Trends Company ▌ FY2023: Substantial increases in both net sales and operating profit mainly in the Mobility field owing to the effects of an upswing in demand and high-performance product sales growth ▌ FY2024: Plans for an increase in net sales and a record-high in operating profit

  27. Slide 27: HPP FY2023 Results Analysis

    HPP FY2023 Results Analysis Company ▌ Despite continued sluggish demand in the Industrial field, increase in sales volumes and product mix focusing on the Mobility field; substantial increase in net sales and operating profit on the back of an increase in margins and contributions from foreign excha

  28. Slide 28: HPP Overview of FY2024 Plan

    HPP Overview of FY2024 Plan Company ▌ In addition to continued firm trends in the Mobility field, Electronics-related demand forecast to recover focusing on semiconductors; substantial increase in sales volumes and product mix; plans for an increase in net sales and operating profit by offsetting th

  29. Slide 29: HPP Three Strategic Fields

    HPP Three Strategic Fields Company Net Sales Trends and KPIs in the Three Strategic Fields Growth Growth 11 businesses clarified as strengthening the current PF driving potential in the Drive 2.0 Medium-term Management Plan. Electronics Mobility Molding products, Electronics (semiconductor and Mobil

  30. Slide 30: Housing Company

    Housing Company Masahide Yoshida Company President 29

  31. Slide 31: Housing Company Performance Trends

    Housing Performance Trends Company ▌ FY2023: Decrease in net sales and operating profit owing to the prolonged slump in new housing construction market conditions and the substantial impact of soaring component costs ▌ FY2024: Conditions throughout the new housing construction market expected to exh

  32. Slide 32: Housing FY2023 Results Analysis

    Housing FY2023 Results Analysis Company ▌ While operating profit in the Renovation Business increased on the back of successful efforts to capture firm demand by strengthening the personnel structure, operating profit declined substantially in overall terms owing to a downturn in the number of house

  33. Slide 33: Housing Overview of FY2024 Plan

    Housing Overview of FY2024 Plan Company ▌ Expecting a modest recovery in Housing Business market conditions; despite a decrease in the number of houses sold, net sales essentially in line with the previous year owing to an increase in unit prices; plans for an increase in operating profit due to the

  34. Slide 34: Housing KPIs by Business and Measures to Strengthen Profitability

    Housing KPIs by Business and Measures to Strengthen Profitability Company Housing Business Renovation Business New Housing Orders (YoY) Number of Orders by Type of Construction (YoY) Orders by Renovation Product • FY2023: New housing orders slightly exceeded • Steady increase in orders by strengthen

  35. Slide 35: Urban Infrastructure & Environmental Products Company

    Urban Infrastructure & Environmental Products Company Yoshiyuki Hirai Company President 34

  36. Slide 36: UIEP Company Performance Trends

    UIEP Performance Trends Company ▌ FY2023: Despite a decrease in housing demand and stagnant construction market conditions, increase in net sales and operating profit owing to thoroughgoing efforts to secure margins and expand sales of prioritized products; second consecutive FY of record-high opera

  37. Slide 37: UIEP FY2023 Results Analysis

    UIEP FY2023 Results Analysis Company ▌ Despite a decline in housing demand in Japan and stagnant non-residential market conditions, took thoroughgoing steps to secure margins; also controlled fixed costs and secured an increase in net sales and operating profit; results fell below forecasts (January

  38. Slide 38: UIEP Overview of FY2024 Plan

    UIEP Overview of FY2024 Plan Company ▌ While housing and non-residential market conditions in Japan are expected to remain stagnant in the 1H, projecting a gradual recovery from the 2H ▌ Plans for an increase in net sales and operating profit by improving selling prices in response to the upswing in

  39. Slide 39: UIEP Three Strategic Fields

    UIEP Three Strategic Fields Company Net sales in the Three Strategic Fields and KPI’s Building and Performance Construction and Fire resistant and non- Pipe Systems materials (railroad flammable materials industrial piping Infrastructures Composite Materials sleepers, etc.) Pipe and joint materials

  40. Slide 40: Medical Business

    Medical Business Eiichi Takahashi President of SEKISUI MEDICAL CO., LTD 39

  41. Slide 41: Medical Business Performance Trends

    Medical Performance Trends Business ▌ FY2023: Despite an increase in net sales owing to higher diagnostics demand in Japan, firm trends in new pharmaceutical ingredients, and the impact of foreign exchange, decrease in operating profit due to such factors as the substantial impact of the decline in

  42. Slide 42: Medical FY2023 Results Analysis

    Medical FY2023 Results Analysis Business ▌ Increase in demand for infectious disease testing in Japan and firm trends in new pharmaceutical ingredients; despite an upswing in overseas sales on the back of an increase in sales of blood coagulation reagents in China, decrease in operating profit owing

  43. Slide 43: Medical Overview of FY2024 Plan

    Medical Overview of FY2024 Plan Business ▌ Target a substantial increase in net sales and record-high operating profit by capturing continued strong demand for diagnostics reagents and increasing sales of new pharmaceutical ingredients in Japan, while focusing on expanding sales of blood coagulation

  44. Slide 44: Medical Overview by Business

    Medical Overview by Business Business Net sales by Business and Overview of Progress Overseas testing Diagnostics (Japan) Diagnostics (overseas) system • FY2023: Increase in demand for infectious disease testing • FY2023: Despite a drop in sale for such products as COVID-19 diagnostics kits in the U

  45. Slide 45: Forward-looking statements

    This slide presentation contains forward-looking statements. These statements are based on current expectations and beliefs. However, actual results may differ from those expressed or implied due to a number of factors and uncertainties such as changes in the global economy and our business, competi

  46. Slide 46: Housing Company Results and Plan

    Housing Company Results and Plan 1. Main data in Housing business 5zzzzzzzzzzzzz FY2023 FY2022 1H 2H Full Year 1H 2H Full Year Net sales (JPY billion) 264.8 264.9 529.7 260.2 277.2 537.4 Housing 175.3 172.7 348.0 177.2 186.4 363.6 CONSOLIDATED Renovation 50.9 52.4 103.3 47.0 50.3 97.3 Other 38.6 39.

  47. Slide 47: Housing Company Results and Plan: Orders and Starts

    Housing Company Results and Plan 2. Housing orders FY2024 Plan FY2023 FY2022 (Millions of yen) 1H 2H Full Year 1H 2H Full Year 1H 2H Full Year New construction ・Renovation Year-start Backlog 139,200 137,000 - 164,300 147,200 - 185,000 186,900 - Growth Rate -15% -7% - -11% -21% - ±0% -3% - New Orders

  48. Slide 48: Various Performance Data

    Various Performance Data Group-wide FY2023 FY2022 ■Net Sales (JPY billion) 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q HPP 96.1 104.2 106.0 106.6 99.1 102.4 97.9 97.0 Housing 121.0 143.8 126.7 138.1 115.7 144.5 129.0 148.2 UIEP 51.3 58.4 59.8 65.3 50.1 60.3 59.2 64.7 Medical 20.5 23.2 23.7 25.3 20.6 22.3 22.4 24.4 HPP

  49. Slide 49: Various Performance Data

    Various Performance Data Industrial field 2023年度 2022年度 ■Net Sales (JPY billion) 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q Labor-saving product 4.9 5.2 4.8 5.6 6.0 5.6 4.8 5.3 Environmentally friendly product 1.7 2.1 2.0 2.2 1.9 1.9 2.1 2.1 Housing 2023年度 2022年度 ■Net Sales (JPY billion) 上期 下期 上期 下期 Housing 6.7 7.9 9.

  50. Slide 50: SEKISUI

    SEKISUI Copyright® SEKISUI CHEMICAL CO., LTD.

Sekisui Chemical — FY2023 Earnings Presentation on 6ix